Session Chair Profile
M.D., Clinical Professor of Medicine, Yale School of Medicine
Biography
William K. Oh, M.D., is currently the Director of Precision Medicine at Yale Cancer Center and a Professor of Medicine (Medical Oncology) at Yale School of Medicine, roles he assumed in October 2024. As part of a newer initiative at Yale, he is focused on building a cohesive program in precision cancer medicine that integrates basic and translational science, clinical trials, and Smilow Cancer Hospital’s Precision Medicine Tumor Board. A central goal of his work is to increase the routine use of molecular and genetic testing for all cancer patients to improve outcomes. Dr. Oh is also dedicated to delivering multidisciplinary care for prostate cancer patients, a priority he has maintained for over 25 years. He has been recognized as a Top Doctor by Castle Connolly, New York Magazine, and Super Doctors. Additionally, he continues his commitment to teaching and advancing research in the field.
Previously, Dr. Oh was a Clinical Professor of Medicine at Icahn School of Medicine. He is an internationally recognized medical oncologist with extensive experience in clinical and translational research, holding leadership roles in both academia and industry. He has authored more than 350 articles, reviews, books, and book chapters related to genitourinary cancers. Dr. Oh has conducted numerous clinical cancer trials and served in key invited roles for ASCO, ACS, and AUA. He has also held the position of Chief Medical Officer for Sema4, a genomics and health intelligence company, as well as the Prostate Cancer Foundation.
Session Abstract – PMWC 2025 Silicon Valley
Track Chair: Razelle Kurzrock, Medical College of Wisconsin
- PMWC 2025 Award Ceremony:
Luminary Honoree: Hedvig Hricak, Memorial Sloan Kettering
Pioneer Honoree: Michael E. Phelps, UCLA - Keynote: Precision Imaging for Precision Medicine
- Hedvig Hricak, Memorial Sloan Kettering
- Keynote: PET Imaging and Theranostics: Revolutionizing Cancer Detection and Treatment
- Michael E. Phelps, UCLA
- Radiopharmaceuticals for Cancer Therapy (PANEL)
Chair: Wiliam Oh, Yale Caner Center
- Naga Vara Kishore Pillarsetty, Memorial Sloan Kettering
- Jones Nauseef, Convergent Therapeutics
- Thomas Hope, UCSF
- Advancements in Digital Imaging: Enhancing Accuracy in Cancer Diagnostics
Chair: Razelle Kurzrock, Medical College of Wisconsin
- Hedvig Hricak, Memorial Sloan Kettering
- Eliot Siegel, VA Maryland Healthcare System
- Sharmila Majumdar, UCSF
- Wafik El-Deiry, Brown University - Digitalizing Oncology Care: Challenges and Opportunities (PANEL)
Chair: Christian Wolfrum, Siemens Healthineers
- Ashley Smith, Varian
- Marshall Pitz, Manitoba Cancer Care
- Measuring Tumor Aggressiveness: How Nanotechnology is Shaping the Future of Cancer Diagnostics
- Marija Plodinec, ARTIDIS
- Alastair Thompson, Baylor College of Medicine
- Stacey Tinianov, Advocates for Collaborative Education
- Overcoming Health System Barriers and Redefining Oncology Endpoints: The Role of MRD
- Krupa Paranjpe, Sanofi - Unlocking MRD Testing and Beyond: Combining Ultra-High Sensitivity WGS with Low Cost
- Gilad Almogy, Ultima Genomics - Ultra-Rapid NGS Testing: Why Time Matters
- Luca Quagliata, ThermoFisher
- Ibiayi Dagogo-Jack, Massachusetts General Hospital
- PMWC Showcase
- Tuvik Beker, Pangea Biomed
- Navigating Regulatory Hurdles and Reimbursement Pathways for Oncology Innovations
Chair: Sheila Walcoff, Goldbug Strategies
- Wui-Jin Koh, NCCN - Gabriel A. Bien-Willner, Palmetto GBA
- Erin Satterwhite, Optum Specialty Pharmacy
